Bone Medical's level one ADR program granted
Monday, 08 August, 2005
Bone Medical (ASX:BNE) has received approval for a level one American Depository Receipt (ADR) program with receipts tradable in the over-the-counter market under the code BMEDY.
The Bank of New York will serve as the depositary bank.
"The ADR program will allow US investors to purchase Bone Medical stock from their local stockbroker, broaden Bone Medical's shareholder base and allow our shares to be traded in the same arena as our global peers," said Bone Medical's CEO Michael Redman in a statement. "Furthermore, the ADR program allows investment by institutions that are only permitted to buy US-based securities."
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
